{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:57:25Z","timestamp":1793908645517,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08038"],"award-info":[{"award-number":["22K08038"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75107-8","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T02:02:24Z","timestamp":1728871344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction"],"prefix":"10.1038","volume":"14","author":[{"given":"Kento","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-046X","authenticated-orcid":false,"given":"Kanji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Okishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Tochiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seita","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Seko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihisa","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Okanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"75107_CR1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig, J. et al. Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc.55, 434\u2013438 (1980).","journal-title":"Mayo Clin. Proc."},{"key":"75107_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature444, 840\u2013846 (2006).","journal-title":"Nature"},{"key":"75107_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","volume":"14","author":"H Tilg","year":"2008","unstructured":"Tilg, H. & Moschen, A. R. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med.14, 222\u2013231 (2008).","journal-title":"Mol. Med."},{"key":"75107_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi, K. et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology45, 1366\u20131374 (2007).","journal-title":"Hepatology"},{"key":"75107_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/ilar.43.2.57","volume":"43","author":"AM Schuler","year":"2002","unstructured":"Schuler, A. M. & Wood, P. A. Mouse models for disorders of mitochondrial fatty acid beta-oxidation. ILAR J.43, 57\u201365 (2002).","journal-title":"ILAR J."},{"key":"75107_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day, C. P. & James, O. F. Steatohepatitis: a tale of two hit? Gastroenterology114, 842\u2013845 (1998).","journal-title":"Gastroenterology"},{"key":"75107_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"6","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med.6, 497\u2013509 (2024).","journal-title":"N Engl. J. Med."},{"key":"75107_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41374-021-00680-9","volume":"102","author":"K Yano","year":"2022","unstructured":"Yano, K. et al. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice. Lab. Invest.102, 281\u2013289 (2022).","journal-title":"Lab. Invest."},{"key":"75107_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-022-01149-x","volume":"7","author":"X Wen","year":"2022","unstructured":"Wen, X. et al. Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal. Transduct. Target. Ther.7, 298 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"75107_CR10","doi-asserted-by":"crossref","unstructured":"Lin, R. et al. Meta-analysis: efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non-alcoholic steatohepatitis and non-alcoholic steatohepatitis-related fibrosis. Aliment. Pharmacol. Ther.31 (2024).","DOI":"10.1111\/apt.17889"},{"key":"75107_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMoa2304286","volume":"14","author":"R Loomba","year":"2023","unstructured":"Loomba, R. et al. Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH. N. Engl. J. Med.14, 998\u20131008 (2023).","journal-title":"N Engl. J. Med."},{"key":"75107_CR12","doi-asserted-by":"publisher","first-page":"129834","DOI":"10.1016\/j.bbagen.2020.129834","volume":"1865","author":"KH Kim","year":"2021","unstructured":"Kim, K. H. & Lee, M. S. GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH. Biochim. Biophys. Acta Gen. Subj.1865, 129834 (2021).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"75107_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.tem.2021.08.008","volume":"32","author":"S Keipert","year":"2021","unstructured":"Keipert, S. & Ost, M. Stress-induced FGF21 and GDF15 in obesity and obesity resistance. Trends Endocrinol. Metab.32, 904\u2013915 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"75107_CR14","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","volume":"20","author":"EC Hsiao","year":"2000","unstructured":"Hsiao, E. C. et al. Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol. Cell. Biol.20, 3742\u20133751 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"75107_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pharmthera.2019.02.008","volume":"198","author":"SJ Baek","year":"2019","unstructured":"Baek, S. J. & Eling, T. Growth differentiation factor 15 (GDF15): a survival protein with therapeutic potential in metabolic diseases. Pharmacol. Ther.198, 46\u201358 (2019).","journal-title":"Pharmacol. Ther."},{"key":"75107_CR16","doi-asserted-by":"publisher","first-page":"1264530","DOI":"10.3389\/fendo.2023.1264530","volume":"25","author":"J Jena","year":"2023","unstructured":"Jena, J., Garc\u00eda-Pe\u00f1a, L. M. & Pereira, R. O. The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response. Front. Endocrinol. (Lausanne)25, 1264530 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"75107_CR17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat. Rev. Endocrinol.17, 592\u2013607 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"75107_CR18","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1007\/s00018-020-03748-9","volume":"78","author":"S Klaus","year":"2021","unstructured":"Klaus, S., Igual Gil, C. & Ost, M. Regulation of diurnal energy balance by mitokines. Cell. Mol. Life Sci.78, 3369\u20133384 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"75107_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1247\/csf.20013","volume":"45","author":"SH Back","year":"2020","unstructured":"Back, S. H. Roles of the translation initiation factor eIF2\u03b1 phosphorylation in cell structure and function. Cell. Struct. Funct.45, 65\u201376 (2020).","journal-title":"Cell. Struct. Funct."},{"key":"75107_CR20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1210\/me.2007-0313","volume":"22","author":"M Suzuki","year":"2008","unstructured":"Suzuki, M. et al. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol. Endocrinol.22, 1006\u20131014 (2008).","journal-title":"Mol. Endocrinol."},{"key":"75107_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tem.2008.06.002","volume":"7","author":"M Kuro-o","year":"2008","unstructured":"Kuro-o, M. Endocrine FGFs and Klothos: emerging concepts. Trends Endocrinol. Metab.7, 239\u2013245 (2008).","journal-title":"Trends Endocrinol. Metab."},{"key":"75107_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cmet.2014.07.012","volume":"20","author":"BM Owen","year":"2014","unstructured":"Owen, B. M. et al. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell. Metab.20, 670\u2013677 (2014).","journal-title":"Cell. Metab."},{"key":"75107_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","volume":"619","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. GDF15 promotes weight loss by enhancing energy expenditure in muscle. Nature619, 143\u2013150 (2023).","journal-title":"Nature"},{"key":"75107_CR24","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/hep.28820","volume":"64","author":"S Tanaka","year":"2016","unstructured":"Tanaka, S. et al. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology64, 1994\u20132014 (2016).","journal-title":"Hepatology"},{"key":"75107_CR25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/nu16050734","volume":"5","author":"K Fichtner","year":"2024","unstructured":"Fichtner, K. et al. GFRAL is widely distributed in the brain and peripheral tissues of mice. Nutrients5, 734 (2024).","journal-title":"Nutrients"},{"key":"75107_CR26","doi-asserted-by":"publisher","first-page":"e202201495","DOI":"10.26508\/lsa.202201495","volume":"11","author":"C Igual Gil","year":"2022","unstructured":"Igual Gil, C. et al. Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior. Life Sci. Alliance11, e202201495 (2022).","journal-title":"Life Sci. Alliance"},{"key":"75107_CR27","doi-asserted-by":"publisher","first-page":"24869","DOI":"10.18632\/oncotarget.15276","volume":"15","author":"A Sasahara","year":"2017","unstructured":"Sasahara, A. et al. An autocrine\/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells. Oncotarget15, 24869\u201324881 (2017).","journal-title":"Oncotarget"},{"key":"75107_CR28","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.molmet.2022.101589","volume":"65","author":"S Patel","year":"2022","unstructured":"Patel, S. et al. Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice. Mol. Metab.65, 101589 (2022).","journal-title":"Mol. Metab."},{"key":"75107_CR29","doi-asserted-by":"publisher","first-page":"102322","DOI":"10.1016\/j.redox.2022.102322","volume":"52","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox Biol.52, 102322 (2022).","journal-title":"Redox Biol."},{"key":"75107_CR30","doi-asserted-by":"publisher","first-page":"105569","DOI":"10.1016\/j.isci.2022.105569","volume":"25","author":"B Xie","year":"2022","unstructured":"Xie, B. et al. Hepatocyte-derived GDF15 suppresses feeding and improves insulin sensitivity in obese mice. iScience25, 105569 (2022).","journal-title":"iScience"},{"key":"75107_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","volume":"29","author":"S Patel","year":"2019","unstructured":"Patel, S. et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell. Metab.29, 707\u2013718 (2019).","journal-title":"Cell. Metab."},{"key":"75107_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai, V. W. W. et al. The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell. Metab.28, 353\u2013368 (2018).","journal-title":"Cell. Metab."},{"key":"75107_CR33","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","volume":"26","author":"R Suriben","year":"2020","unstructured":"Suriben, R. et al. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice. Nat. Med.26, 1264\u20131270 (2020).","journal-title":"Nat. Med."},{"key":"75107_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.freeradbiomed.2017.07.011","volume":"112","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells. Free Radic. Biol. Med.112, 49\u201359 (2017).","journal-title":"Free Radic Biol. Med."},{"key":"75107_CR35","doi-asserted-by":"publisher","first-page":"bqac030","DOI":"10.1210\/endocr\/bqac030","volume":"163","author":"G Xu","year":"2022","unstructured":"Xu, G. et al. Deletion of Gdf15 reduces ER stress-induced beta-cell apoptosis and diabetes. Endocrinology163, bqac030 (2022).","journal-title":"Endocrinology"},{"key":"75107_CR36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/carcin\/bgq016","volume":"31","author":"SH Lee","year":"2010","unstructured":"Lee, S. H., Krisanapun, C. & Baek, S. J. NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C\/EBPbeta and ATF3. Carcinogenesis31, 719\u2013728 (2010).","journal-title":"Carcinogenesis"},{"key":"75107_CR37","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/j.gastro.2020.12.015","volume":"160","author":"Y Myojin","year":"2021","unstructured":"Myojin, Y. et al. Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production. Gastroenterology160, 1741\u20131754 (2021).","journal-title":"Gastroenterology"},{"key":"75107_CR38","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jhep.2019.12.004","volume":"72","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation. J. Hepatol.72, 976\u2013989 (2020).","journal-title":"J. Hepatol."},{"key":"75107_CR39","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cmet.2022.03.005","volume":"34","author":"S Katsumura","year":"2022","unstructured":"Katsumura, S. et al. Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure. Cell. Metab.34, 564\u2013580 (2022).","journal-title":"Cell. Metab."},{"key":"75107_CR40","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","volume":"139","author":"J Dushay","year":"2010","unstructured":"Dushay, J. et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology139, 456\u2013463 (2010).","journal-title":"Gastroenterology"},{"key":"75107_CR41","doi-asserted-by":"publisher","first-page":"165798","DOI":"10.1016\/j.bbadis.2020.165798","volume":"1866","author":"L Rochette","year":"2020","unstructured":"Rochette, L. et al. Functional roles of GDF15 in modulating microenvironment to promote carcinogenesis. Biochim. Biophys. Acta Mol. Basis Dis.1866, 165798 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"75107_CR42","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.bbrc.2012.11.137","volume":"430","author":"S Shimizu","year":"2013","unstructured":"Shimizu, S. et al. Proteasome inhibitor MG132 induces NAG-1\/GDF15 expression through the p38 MAPK pathway in glioblastoma cells. Biochem. Biophys. Res. Commun.430, 1277\u20131282 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"75107_CR43","doi-asserted-by":"publisher","first-page":"E292","DOI":"10.1152\/ajpendo.00101.2017","volume":"3","author":"T Xie","year":"2017","unstructured":"Xie, T. & Leung, P. S. Fibroblast growth factor 21: a regulator of metabolic disease and health span. Am. J. Physiol. Endocrinol. Metab.3, E292\u2013E302 (2017).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"75107_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki, T. et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell. Metab.5, 415\u2013425 (2007).","journal-title":"Cell. Metab."},{"key":"75107_CR45","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00125-014-3475-6","volume":"58","author":"SH Kim","year":"2015","unstructured":"Kim, S. H. et al. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia58, 809\u2013818 (2015).","journal-title":"Diabetologia"},{"key":"75107_CR46","doi-asserted-by":"publisher","first-page":"29751","DOI":"10.1074\/jbc.M114.565960","volume":"289","author":"S Jiang","year":"2014","unstructured":"Jiang, S. et al. Fibroblast growth factor 21 is regulated by the IRE1\u03b1-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis. J. Biol. Chem.289, 29751\u201329765 (2014).","journal-title":"J. Biol. Chem."},{"key":"75107_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.redox.2018.01.013","volume":"16","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid \u03b2-oxidation and ketogenesis via activating XBP1 signaling in liver. Redox Biol.16, 87\u201396 (2018).","journal-title":"Redox Biol."},{"key":"75107_CR48","doi-asserted-by":"publisher","first-page":"E5886","DOI":"10.1073\/pnas.1604435113","volume":"113","author":"S Kanda","year":"2016","unstructured":"Kanda, S. et al. Autonomous translational pausing is required for XBP1u mRNA recruitment to the ER via the SRP pathway. Proc. Natl. Acad. Sci. U. S. A.113, E5886\u2013E5895 (2016).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"75107_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2005.10.001","volume":"45","author":"SJ Baek","year":"2006","unstructured":"Baek, S. J. & Eling, T. E. Changes in gene expression contribute to cancer prevention by COX inhibitors. Prog. Lipid Res.45, 1\u201316 (2006).","journal-title":"Prog Lipid Res."},{"key":"75107_CR50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.bcp.2012.11.025","volume":"85","author":"X Wang","year":"2013","unstructured":"Wang, X., Baek, S. J. & Eling, T. E. The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer. Biochem. Pharmacol.85, 597\u2013606 (2013).","journal-title":"Biochem. Pharmacol."},{"key":"75107_CR51","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","volume":"33","author":"SM Houten","year":"2010","unstructured":"Houten, S. M. & Wanders, R. J. A general introduction to the biochemistry of mitochondrial fatty acid \u03b2-oxidation. J. Inherit. Metab. Dis.33, 469\u2013477 (2010).","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75107-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75107-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75107-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T10:53:24Z","timestamp":1732877604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75107-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75107"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75107-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4123115\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23993"}}